Key opinion leaders from across the hematologic oncology realm shared their biggest takeaways from the 2023 SOHO Annual Meeting.
At the 2023 SOHO Annual Meeting in Houston, Texas, experts presented on the latest emerging data, changing treatment approaches, and next stages of research across a variety of hematologic malignancies. Alongside broader presentations, attendees also had the opportunity to meet with experts in smaller groups for more nuanced discussions about the latest trends in different areas and how they approach the treatment of various malignancies within clinical practice.
In interviews with OncLive®, key opinion leaders from across the hematologic oncology realm shared their biggest takeaways from the 2023 SOHO Annual Meeting.
Erba highlights some of the key developments and emerging data from across the myelodysplastic syndrome and acute myeloid leukemia spaces. Lin points to presentations on CAR T-cell therapies, bispecific antibodies, and novel immunotherapies under investigation in multiple myeloma.
Philips explains that meetings such as the SOHO Annual Meeting allow for clinicians to share opinions on different data and treatment approaches in practice. Ansell concludes by detailing the emergence of immunotherapy agents and how they could be utilized in different sequences or combinations for patients with lymphoma.